INGR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Ingredion Inc (INGR) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has shown strong net income and EPS growth in the latest quarter, the technical indicators are neutral to bearish, and insider selling activity raises concerns. Additionally, the options data and analyst ratings do not suggest a strong upward momentum in the near term. Holding or waiting for a better entry point is recommended.
The MACD is negative and expanding, indicating bearish momentum. RSI is neutral at 40.382, and moving averages are converging, showing no clear trend. The stock is trading near its pivot level of 118.666, with support at 114.858 and resistance at 122.475. Overall, the technical indicators suggest a neutral to bearish trend.
Net income increased by 73.68% YoY, and EPS grew by 79.02% YoY in Q4 2025, showing strong profitability improvements. Hedge funds have significantly increased their buying activity by 137.50% over the last quarter.
Insider selling has surged dramatically, with a 7294996.72% increase in the last month. The company's Q4 results missed consensus estimates, and a facility outage has been a headwind. Additionally, the pre-market price of $117.90 is below the pivot level, indicating weak momentum.
In Q4 2025, revenue dropped to $1.757 billion (-2.39% YoY), but net income increased to $165 million (+73.68% YoY), and EPS rose to $2.56 (+79.02% YoY). Gross margin declined slightly to 24.47% (-1.88% YoY).
Analyst ratings are mixed. UBS raised its price target to $124 but maintained a Neutral rating. BMO Capital lowered its price target to $120 and kept a Market Perform rating, citing weaker profits in the Texture & Healthful Solutions segment. Barclays raised its price target to $128 but noted headwinds from a facility outage. The consensus reflects cautious optimism but no strong buy signals.
